Acobiom is developing Panthera Dx, an innovative in vitro diagnostic blood test powered by artificial intelligence, designed to guide the choice of first-line chemotherapy for pancreatic cancer

Aíma is a DeepTech start-up whose mission is to tackle the ‘needle in a haystack’ challenge in oncology: detecting virtually invisible tumour signals that account for less than 1% of circulating DNA.

ClearSurgery is a DeepTech start-up that deploys the CE-certified ClearSphere solution in the operating theatre. ClearSphere uses the Apple Vision Pro spatial computer to create the surgeon’s Personal Immersive Sphere.

Eclipse NeuroTech’s mission is to restore speech to people with paralysis using a new-generation (epidural) brain implant, which is placed on the protective membrane of the brain without ever penetrating it.

Nawu Diagnostics is developing a compact, connected diagnostic solution that can accurately detect and identify respiratory infections in 20 minutes, directly from patients’ breath.

Oncelia is a young start-up developing a quick and painless smart bra (PHIBRA) designed to help prevent breast cancer. Its aim is to make screening more accessible and regular.

Smartery is pushing the boundaries of open surgery by developing the first ‘off-the-shelf’ endovascular solution designed specifically for the ascending aorta: a minimally invasive stent graft that is ready for immediate use in emergency situations.

Swiift Imaging has developed HAPTUS and is revolutionising access to ultrasound scanning through an unprecedented disruptive innovation (a tele-ultrasound solution), enabling high-quality diagnosis regardless of time or place.